All company analyses

ELV · November 22, 2026 · Free preview

Elevance Health discounted cash flow valuation

How much of Elevance’s earnings can shareholders receive after medical claims and capital required for new members?

Third-quarter premium revenue was $41.70 billion and the benefit expense ratio was 90.6%. In November management reaffirmed at least $22 of full-year GAAP EPS. Company filing or announcement

Read the full valuation

See fair value against the November 20 close, the net margin that price implies, three operating scenarios and the effect of changing the discount rate or long-run growth.

One-time purchase in USD for this valuation · Includes a reusable private access link

Restore this purchase · Owner sign-in

ELV operating forecast